A
Atea Pharmaceuticals (AVIR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.... Read more
- USD2.94
- USD2.98
- USD2.92
- USD4.15
- 2.10%
- --
- 273.89k
- 438.29k
- 248M
- 2.46
- -19.40%
Stock News
3 hours ago
Trade court strikes down Trump tariffs: What it means for markets — and what’s next
MarketWatch
4 hours ago
Nvidia discloses more China risks, but CEO praises Trump
Yahoo
5 hours ago
Why Salesforce's beat-and-raise quarter isn't quieting the stock's doubters
CNBC
yesterday
Nvidia CEO Jensen Huang hammers chip controls that 'effectively closed' China market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
